LFTD Partners Inc.

LIFD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Revenue $9.5M $10.7M $13.5M $13.1M $12.5M $12.5M $11.3M $11.2M
Cost of Revenue $5.9M $7.3M $9.5M $8.7M $6.9M $6.8M $7.2M $10.4M
Gross Profit $3.6M $3.4M $4.0M $4.4M $5.6M $5.6M $4.1M $813.7K
Gross Margin 37.5% 31.7% 29.6% 33.7% 45.0% 45.3% 36.5% 7.2%
Operating Expenses
Research & Development — — — — — $19.8K — —
SG&A Expense — — — — — — — —
Operating Income $-582.7K $-122.3K $-517.1K $659.5K $2.4M $-104.9K $716.7K $495.3K
Operating Margin -6.1% -1.1% -3.8% 5.0% 18.9% -0.8% 6.3% 4.4%
Interest Expense $90.5K $92.9K $38.0K $24.0K $24.4K $24.2K $24.4K $37.2K
Pretax Income $-657.7K $-1.5M $-56.2K $579.1K $2.3M $-114.5K $891.5K $447.5K
Income Tax Expense $-134.5K $-398.0K $-102.6K $38.6K $689.3K $-27.2K $-2.9M $-24.0K
Net Income $-523.2K $-1.1M $23.6K $617.6K $1.7M $-141.7K $608.6K $423.5K
Net Margin -5.5% -10.7% 0.2% 4.7% 13.3% -1.1% 5.4% 3.8%
EPS (Basic) $-0.04 $-0.08 $0.01 $0.04 $0.11 $-0.01 $0.04 $0.03
EPS (Diluted) $-0.04 $-0.08 $0.00 $0.04 $0.10 $-0.01 $0.04 $0.03
Shares Outstanding (Basic) 14.8M 14.8M 14.6M 14.6M 14.5M 14.2M 14.1M 14.1M
Shares Outstanding (Diluted) 14.8M 14.8M 16.4M 15.4M 16.7M 14.2M 15.9M 15.9M
Dividends Per Share — — — — — — — —
← Newer Page 2 of 5 Older →